CureZone   Log On   Join
Pegaspargase (Oncaspar): As An Antineoplastic Agent
rajupharma Views: 89
Published: 9 months ago

Pegaspargase (Oncaspar): As An Antineoplastic Agent

Pegaspargase, trade name Oncaspar, mainly is a modified enzyme considered as an antineoplastic agent. It is a form of L-asparaginase which has undergone PEGylation. The pegaspargase injection is used in the treatment of acute lymphoblastic leukemia. As an enzyme it interferes with natural substances required for malignant cell growth. It works by destroying/inhibiting the progression of cancer cells. Pegaspargase is available as a liquid to be injected into a muscle or infused intravenously (into a vein) over 60/120 minutes by a health specialist in a medical office or hospital outpatient clinic.


Printer-friendly version of this page Email this message to a friend
Alert Moderators
Report Spam or bad message  Alert Moderators on This GOOD Message

This Forum message belongs to a larger discussion thread. See the complete thread below. You can reply to this message!


Donate to CureZone

CureZone Newsletter is distributed in partnership with

Contact Us - Advertise - Stats

Copyright 1999 - 2023

0.313 sec, (1)